| Cash Flow | 2025-06-30 |
|---|---|
| Net loss | -353,348 |
| Prepaid expenses and other current assets | -22,476 |
| Accrued expenses and other | -10,218 |
| Accounts payable | -1,057 |
| Accrued compensation | 244,346 |
| Share-based compensation | 0 |
| Accretion to redemption value on convertible notes | 0 |
| Non-cash interest on convertible notes | 36,365 |
| Interest expense on loan payable | 0 |
| Net cash used in operating activities | -61,436 |
| Proceeds from issuance of loan payable | 0 |
| Net cash provided by financing activities | 0 |
| Net change in cash and cash equivalents | -61,436 |
Mosaic ImmunoEngineering Inc. (CPMV)
Mosaic ImmunoEngineering Inc. (CPMV)